70 %. This is the recommended participation rate in the national breast cancer screening program (PNDOCs) by European bodies to effectively reduce mortality related to this disease.
But the latest figures published by Public Health France are far from the ‘account’ and even fall down. In 2024, the participation rate was estimated at 44 %, against 46.3 % for the period 2023-2024 and 46.7 % for 2022-2023.
The analysis of the 2024 data reveals important territorial disparities. So how to explain this continuous decrease in public health France is advancing a surprising explanation: “Since 2020 and the epidemic of COVID-19, disturbances are observed in sending invitations and in participation. From January 1, 2024, the sending of invitations is made by health insurance. For this year, data relating to the number of women invited is not available to date, health insurance is not able to provide them for the moment. ”
A major public health issue
Recall that with approximately 61,000 new cases and 12,000 deaths estimated in 2023, breast cancer remains the leading cause of cancer and cancer death in women in France.
